Your browser doesn't support javascript.
loading
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity.
Gressier, Elise; Schulte-Schrepping, Jonas; Petrov, Lev; Brumhard, Sophia; Stubbemann, Paula; Hiller, Anna; Obermayer, Benedikt; Spitzer, Jasper; Kostevc, Tomislav; Whitney, Paul G; Bachem, Annabell; Odainic, Alexandru; van de Sandt, Carolien; Nguyen, Thi H O; Ashhurst, Thomas; Wilson, Kayla; Oates, Clare V L; Gearing, Linden J; Meischel, Tina; Hochheiser, Katharina; Greyer, Marie; Clarke, Michele; Kreutzenbeck, Maike; Gabriel, Sarah S; Kastenmüller, Wolfgang; Kurts, Christian; Londrigan, Sarah L; Kallies, Axel; Kedzierska, Katherine; Hertzog, Paul J; Latz, Eicke; Chen, Yu-Chen E; Radford, Kristen J; Chopin, Michael; Schroeder, Jan; Kurth, Florian; Gebhardt, Thomas; Sander, Leif E; Sawitzki, Birgit; Schultze, Joachim L; Schmidt, Susanne V; Bedoui, Sammy.
Affiliation
  • Gressier E; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia. elise.gressier07@gmail.com.
  • Schulte-Schrepping J; Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Petrov L; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
  • Brumhard S; Translational Immunology, Berlin Institute of Health (BIH) & Charité University Medicine, Berlin, Germany.
  • Stubbemann P; Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Hiller A; Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Obermayer B; Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Spitzer J; Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Core Unit Bioinformatics, Berlin, Germany.
  • Kostevc T; Institute of Innate Immunity, University of Bonn, Bonn, Germany.
  • Whitney PG; Translational Immunology, Berlin Institute of Health (BIH) & Charité University Medicine, Berlin, Germany.
  • Bachem A; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Odainic A; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • van de Sandt C; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Nguyen THO; Institute of Innate Immunity, University of Bonn, Bonn, Germany.
  • Ashhurst T; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Wilson K; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Oates CVL; Sydney Cytometry Core Research Facility, Charles Perkins Centre, Centenary Institute and University of Sydney, Sydney, New South Wales, Australia.
  • Gearing LJ; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Meischel T; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Hochheiser K; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Greyer M; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Clarke M; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kreutzenbeck M; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Gabriel SS; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kastenmüller W; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kurts C; Institute of Innate Immunity, University of Bonn, Bonn, Germany.
  • Londrigan SL; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kallies A; Würzburg Institute of Systems Immunology, Max Planck Research Group, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Kedzierska K; Institute of Experimental Immunology, University of Bonn, Bonn, Germany.
  • Hertzog PJ; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Latz E; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Chen YE; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Radford KJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Chopin M; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Schroeder J; Institute of Innate Immunity, University of Bonn, Bonn, Germany.
  • Kurth F; Mater Research Institute, The University of Queensland, Brisbane, Queensland, Australia.
  • Gebhardt T; Mater Research Institute, The University of Queensland, Brisbane, Queensland, Australia.
  • Sander LE; Department of Biochemistry, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Sawitzki B; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Schultze JL; Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Schmidt SV; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Bedoui S; Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Nat Immunol ; 24(6): 979-990, 2023 06.
Article in En | MEDLINE | ID: mdl-37188942
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Document type: Article Affiliation country: